Janice Suzann Drew

CIK: 0002091053

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EVMN

Evommune, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

EVMN
Evommune, Inc.
Jun 22, 2026
Exercise(M)
Direct
16.2K shares at avg. $2.99$48K
EVMN
Evommune, Inc.
Jun 22, 2026
Exercise(M)
Direct
3.8K shares at avg. $3.84$15K
EVMN
Evommune, Inc.
Jun 22, 2026
Sale(S)
Direct
20K shares at avg. $22.63$453K
EVMN
Evommune, Inc.
Apr 16, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
73.9K shares-
EVMN
Evommune, Inc.
Dec 9, 2025
Tax Payment(F)
Direct
5.1K shares at avg. $17.84$91K
EVMN
Evommune, Inc.
Nov 7, 2025
Conversion(C)
Direct
1.6K shares-
EVMN
Evommune, Inc.
Nov 5, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
231.3K shares-

		Type	Shares	Price		Ownership
Jun 22, 2026	EVMN Evommune, Inc.	Exercise(M)	16,161	$2.99	$48,321	Direct
Jun 22, 2026	EVMN Evommune, Inc.	Exercise(M)	3,839	$3.84	$14,742	Direct
Jun 22, 2026	EVMN Evommune, Inc.	Sale(S)	20,000	$22.63	$452,600	Direct
Apr 16, 2026	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	73,892	-	-	Direct
Dec 9, 2025	EVMN Evommune, Inc.	Tax Payment(F)	5,074	$17.84	$90,520	Direct
Nov 7, 2025	EVMN Evommune, Inc.	Conversion(C)	1,587	-	-	Direct
Nov 5, 2025	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	231,274	-	-	Direct

1-7 of 7 transactions

About Drew Janice Suzann

Drew Janice Suzann (SEC CIK 0002091053) files insider reports with the SEC as Chief of Dev. Operations of Evommune, Inc. (EVMN).

Signal8 holds 6 ownership filings by Drew Janice Suzann (1 Form 3, 5 Form 4), filed between Nov 5, 2025 and Jun 24, 2026. Those filings report 7 transactions, from Nov 5, 2025 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Drew Janice Suzann's filings is in PALO ALTO, CA.

Recent filings by Drew Janice Suzann

Jun 22, 2026: Option exercises of EVMN shares (2 lines, Form 4, code M).
Jun 22, 2026: Open-market sale of EVMN shares (Form 4, code S).
Apr 16, 2026: Grant or award of EVMN derivative securities (Form 4, code A).
Dec 9, 2025: Tax withholding of EVMN shares (Form 4, code F).
Nov 7, 2025: Conversion of EVMN shares (Form 4, code C).

Other insiders filing for Evommune, Inc. (EVMN)

Pena Luis C., President & CEO
Carver Kyle, Chief Financial Officer
KIRSCH ARTHUR S, Director
Patel Jeegar Pravinkumar, Chief Scientific Officer
MCGRAW BENJAMIN F III, Director
Cohen David E, Director

How to read Form 4 transaction codes